Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CO/Thornton
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Thornton, CO

Studies commonly pay $75 to $4,500 per completed study

1,602 clinical trials are currently recruiting participants within 30 miles of Thornton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,602studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Thornton right now

Top 25 of 1,602 recruiting studies, sorted by proximity — each links to its official registry page

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (19.0 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Advanced Vision Research Institute — Longmont, Colorado (19.0 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis N/A Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (12.7 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT02315729)

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG Phase 2 Interventional 60 participants sought
Children's Hospital Colorado — Aurora, Colorado (14.4 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06838676)

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Ovarian Cancer, Advanced Ovarian Carcinoma N/A Interventional 240 participants sought
University of Colorado Cancer Center-Anschutz — Aurora, Colorado (14.4 mi) · Sponsor: Dana-Farber Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT06710548)

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Denver, Colorado (12.7 mi) · Sponsor: Avenzo Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07038343)

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Phase 1 Interventional 248 participants sought
Sarah Cannon Research Institute at Colorado Blood Cancer Institute — Denver, Colorado (12.7 mi) · Sponsor: Nurix Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04830137)

Creative Arts Program to Reduce Burnout in Healthcare Professionals

Burn-Out Syndrome, Post-Traumatic Stress Disorder N/A Interventional 195 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (14.4 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT04276922)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase 3 Interventional 550 participants sought
University of Colorado Denver — Aurora, Colorado (14.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06133972)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Rocky Mountain Lions Eye Institute — Aurora, Colorado (14.4 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

The Vanguard Study: Testing a New Way to Screen for Cancer

Bladder Carcinoma, Breast Carcinoma N/A Interventional 24,000 participants sought
Kaiser Permanente-Rock Creek — Lafayette, Colorado (9.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06995898)

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC) Phase 1 Interventional 30 participants sought
SCRI at HCA HealthONE — Denver, Colorado (12.7 mi) · Sponsor: SHY Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07705334)

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection Phase 2 Interventional 84 participants sought
University of Colorado at Denver ( Site 0108) — Aurora, Colorado (14.4 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT04375800)

Type 1 Diabetes Extension Study

Type 1 Diabetes Mellitus, T1DM N/A Observational 111 participants sought
University of Colorado School of Medicine: Barbara Davis Center for Diabetes — Aurora, Colorado (14.4 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
See eligibility & contact on ClinicalTrials.gov (NCT02734277)

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Esophageal Cancer, Head and Neck Cancer N/A Observational 700 participants sought
University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado (14.4 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT00900419)

SynKIR-310 for Relapsed/Refractory B-NHL

B Cell Lymphoma, NHL, Adult Phase 1 Interventional 36 participants sought
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute — Denver, Colorado (12.7 mi) · Sponsor: Verismo Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06544265)

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Knee Cartilage Defects Phase 3 Interventional 300 participants sought
Orthopedic Centers of Colorado — Parker, Colorado (29.4 mi) · Sponsor: Medipost, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07339111)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis, Amyloid Cardiomyopathy Phase 3 Interventional 587 participants sought
University of Colorado Anschutz — Aurora, Colorado (14.4 mi) · Sponsor: Eidos Therapeutics, a BridgeBio company
See eligibility & contact on ClinicalTrials.gov (NCT06563895)

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Sarcoma Phase 2 Interventional 20 participants sought
University Of Colorado Hospital — Aurora, Colorado (14.4 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT07125183)

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Non-Muscle Invasive Bladder Neoplasms N/A Observational 150 participants sought
Colorado Clinical Research — Lakewood, Colorado (16.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07309445)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Denver, Colorado (12.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)
Google-rated

Top-rated research centers in Thornton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Colorado Clinical Research

8753 Yates Dr #110, Westminster, CO 80031
(720) 980-3668

Western States Clinical Research, Inc.

★ 5.0
4251 Kipling St #540, Wheat Ridge, CO 80033
(303) 940-9773
"Cheri, Mary, and Falon are very fun and competent people . They always answer any questions that I might have.and always go out of their way to make …"
— Mike Sewald, 5★

Paradigm Clinical Research

★ 5.0
7777 W 38th Ave # A118, Wheat Ridge, CO 80033
(303) 463-1947

Advanced Research Institute - Denver

★ 5.0
1830 Franklin St Ste 220, Denver, CO 80218
(303) 353-2660

Colorado Clinical and Translational Sciences Institute (CCTSI) – Anschutz Medical Campus

1890 N Revere Ct, Aurora, CO 80045
(303) 724-1222

CPC Clinical Research & Community Health

★ 4.0
2115 N Scranton St Ste 2040, Aurora, CO 80045
(303) 860-9900
"We are truly blessed to be apart of their patients. My son sees the Hematology office here and since we are newer to this diagnosis and health condit…"
— Missy R., 5★

Alpine Clinical Research Center

★ 5.0
3434 47th St Ste 201, Boulder, CO 80301
(303) 443-7229
"Family mannerisms, upon arrival all are welcomed coming and going. The staff is very skilled with ADLs, and they are quick! They all are thorough wi…"
— Carla Williams, 5★

Denver Research Institute

3401 Quebec St #5000, Denver, CO 80207
(720) 457-0670

Mountain View Clinical Research

★ 4.3
3955 E Exposition Ave #104, Denver, CO 80209
(720) 941-9363
"Such a great organization with helpful, knowledgeable staff!"
— Windsong Forrest, 5★

Clinical trials in Thornton: what's recruiting

The Thornton area currently has 1,602 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Thornton, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism2 studies
  • Heart & Vascular2 studies
  • Liver & Kidney2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Thornton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Thornton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Thornton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Thornton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Thornton safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Thornton?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Thornton.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Thornton typically complete one or two studies per year.

Paid clinical trials near Thornton

Other metros within reach

Denver, CO1,599 Lakewood, CO1,599 Aurora, CO1,563 Greeley, CO163 Fort Collins, CO162 Colorado Springs, CO207 Grand Junction, CO54 Albuquerque, NM341

More of CO

Denver1,599 Lakewood1,599 Aurora1,563 Colorado Springs207 Greeley163 Fort Collins162 Grand Junction54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts